|
|
||||||||
1 Department of Veterinary Biosciences, Ohio State University, Columbus, Ohio 43210; and 2 Department of Veterinary Biomedical Sciences and Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211-3300
| |
ABSTRACT |
|---|
|
|
|---|
The baroreflex function curve is shifted to lower operating
pressures, efferent sympathoexcitatory responses are attenuated, and
sympathoinhibitory responses are potentiated in pregnant compared with
virgin rats. It has been proposed that during pregnancy, elevated
levels of 3
-hydroxy-dihydroprogesterone (3
-OH-DHP), a major
metabolite of progesterone, may contribute to this difference, because
acute intravenous administration of 3
-OH-DHP to virgin female rats
mimics the effects of pregnancy on the baroreflex. To determine whether
changes in the afferent limb might contribute to these baroreflex
responses, the effects of pregnancy and 3
-OH-DHP on aortic depressor
nerve activity were assessed in the current study. Baroreceptor
discharge curves were obtained in Inactin-anesthetized rats by
recording aortic nerve activity during ramp increases and decreases in
mean arterial pressure (MAP) [intravenous phenylephrine and
nitroprusside infusion] before [(control, C) 15 min (E1), and
30 min (E2) after 3
-OH-DHP (220 µg/kg bolus + 22 µg · kg
1 · min
1 infusion
iv)]. Baseline blood pressure was significantly lower in pregnant
(109 ± 4.4 mmHg) compared with virgin (122 ± 2.8 mmHg) rats. The only significant difference in the baroreceptor discharge curves was a decrease in curve midpoint in pregnant rats (virgin = 140 ± 2.7 vs. pregnant = 124 ± 3.6 mmHg). 3
-OH-DHP
had no effect on afferent baroreceptor discharge curves in either
virgin or pregnant groups. These results suggest that
pressure-dependent baroreceptor resetting may contribute to a shift in
the baroreflex curve to lower operating pressures, but cannot
completely explain differences in baroreflex function between virgin
and pregnant animals.
aortic depressor nerve; 3
-hydroxy-dihydroprogesterone; neurosteroid; baroreflex; pregnancy
| |
INTRODUCTION |
|---|
|
|
|---|
PREGNANCY IS ASSOCIATED with many cardiovascular adaptations. For example, blood volume and cardiac output are increased, arterial pressure is decreased, and heart rate (HR) is elevated in pregnant compared with virgin animals (10, 11, 17, 21). Among the adaptations to pregnancy are changes in arterial baroreflex function. Sympathoexcitatory responses to decreases in arterial blood pressure are attenuated and sympathoinhibitory responses to increases in blood pressure are potentiated in pregnant animals (7, 15, 23). In addition, baseline arterial pressure is lower in pregnant animals and the baroreflex function curve is shifted to a lower operating pressure range (1, 7, 15, 23).
The presence of elevated levels of the primary metabolite of
progesterone, 3
-hydroxy-dihydroprogesterone (3
-OH-DHP), may be
one mechanism involved in producing the changes in baroreflex function
during pregnancy. Previous studies in our laboratory have demonstrated
that acute intravenous administration of 3
-OH-DHP to virgin female
rats attenuates sympathoexcitatory responses to decreases in arterial
blood pressure, a response also seen in pregnancy (7, 15,
23). The 3
-OH-DHP metabolite of progesterone belongs to a
class of compounds known as neurosteroids that produce effects through
an action on the central nervous system (CNS). It has been demonstrated
that 3
-OH-DHP is the most potent endogenous positive modulator of
CNS GABAA receptors (25, 26). The progesterone metabolites, 3
-OH-DHP (allopreganolone) and
allotetrahydrodeoxycorticosterone, bind stereospecifically to a unique
site on the GABAA receptor complex and positively modulate
GABA action on GABAA receptors through an allosteric
mechanism (6). Both plasma and CNS concentrations of these
metabolites are increased in pregnancy (5). Previously (12) our laboratory demonstrated that 3
-OH-DHP
potentiated binding of the GABAA receptor ligand
flunitrazepam in brainstem nuclei involved in the arterial baroreflex,
including the nucleus tractus solitarius, caudal ventrolateral medulla,
and rostral ventrolateral medulla (RVLM). A subsequent study
(8) revealed that after a hypotensive challenge,
expression of the early gene, c-fos, was attenuated in the
RVLM of pregnant compared with virgin female rats.
Changes in baroreflex function and brainstem c-fos
expression observed during pregnancy are consistent with a potentiation of GABAA receptor function in the RVLM and preliminary
experiments in our laboratory suggest that direct application of
3
-OH-DHP to the RVLM produces changes in baroreflex function similar
to those observed after intravenous administration (13).
These results indicate that CNS effects of 3
-OH-DHP likely
contribute to the effects of pregnancy on arterial baroreflex
function. However, others have demonstrated that circulating and
locally released substances can modulate baroreceptor afferent activity
(2, 3). Whether pregnancy or the primary progesterone
metabolite 3
-OH-DHP have an effect on baroreceptor afferent
discharge that could participate in baroreflex adaptations has not been
addressed. Therefore, the current experiments were designed to evaluate
the effects of pregnancy and of 3
-OH-DHP on the afferent limb of the baroreflex.
| |
METHODS |
|---|
|
|
|---|
Experiments were performed in 51 female Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN) at 3 to 5 mo of age. Before the experiment, daily vaginal smear cytology was used to determine the stage of the estrous cycle and each rat was followed through at least two full estrous cycles. Animals to be included in the pregnant groups (n = 26) were placed with a fertile male, and day 1 of pregnancy was determined when sperm were observed in vaginal smears. Experiments were then performed on pregnant rats on days 20-21. Experiments in rats included in the virgin groups (n = 25) were performed in animals in the estrus stage of the cycle, a time when ovarian hormone levels are low.
Surgical preparation
Rats were anesthetized with Inactin (100 mg/kg ip). The trachea was cannulated and the rat artificially ventilated with room air supplemented with oxygen (small animal ventilator, Harvard Apparatus; South Natick, MA). Body temperature was monitored and maintained at 37°C. The rat was then instrumented with a left femoral arterial and venous catheter to monitor arterial blood pressure and for intravenous administration of supplemental anesthetic (5 mg iv as needed), respectively. Three catheters were also implanted in the left jugular vein for intravenous drug infusion.To verify the effect of pregnancy on efferent baroreflex function in Inactin-anesthetized rats, the left renal nerve was isolated retroperitoneally and placed on a bipolar platinum recording electrode in virgin (n = 13) and pregnant (n = 14) rats. The renal nerve was secured on the electrode with polyvinylsiloxane gel (Coltene President, Mahwah, NJ). A ground wire was sutured to muscle at the incision site and the wound was closed.
Afferent baroreceptor responses were evaluated in a separate set of experiments by recording from the aortic depressor nerve, which has been demonstrated to contain almost exclusively baroreceptor afferent fibers in the rat (24, 29). The aortic nerve in 12 virgin and 12 pregnant rats was isolated through a ventral approach. Once isolated, the nerve was placed on a bipolar platinum recording electrode and secured in place with polyvinylsiloxane gel. A ground wire was sutured to muscle at the incision site, and the wound was closed.
Drugs and Solution
The anesthetic Inactin was obtained from RBI (Natick, MA) and dissolved in sterile water. Phenylephrine (PE) and nitroprusside (NTP) were purchased from Sigma (St. Louis, MO) and diluted in isotonic saline. The primary metabolite of progesterone, 3
-OH-DHP, was also
obtained from Sigma and was dissolved in 40%
-cyclodextrin (RBI).
Experimental Protocol
Efferent nerve activity baroreflex experiments. While the effect of pregnancy on baroreflex function has been previously evaluated in our laboratory in both chloralose-anesthetized (7) and conscious (23) rats, the attenuation in sympathoexcitatory responses to low blood pressures in pregnant chloralose-anesthetized rats is relatively small compared with the conscious preparation. To evaluate whether this may be due to the type of anesthetic used, preliminary experiments using the long-lasting rodent anesthetic Inactin were performed in 13 virgin and 14 pregnant animals.
Similar to previous protocols (7, 23) baroreflex function was evaluated by recording renal sympathetic nerve activity (RSNA) responses to slow ramp (~2 mmHg/s) decreases and increases in mean arterial pressure (MAP) (intravenous NTP and PE infusion, respectively). Nerve activity responses were obtained as MAP was lowered to 50 mmHg and then raised to 200 mmHg from baseline. MAP and RSNA were allowed to recover between pressure ramps. Any nerve activity signal remaining for 30 min after an overdose of anesthetic was defined as electrical noise and subtracted from the nerve activity values.Afferent nerve activity baroreceptor experiments.
Changes in baroreceptor afferent nerve discharge were evaluated by
recording aortic nerve activity (AoNA) responses to slow ramp
decreases and increases in MAP (intravenous NTP and PE infusion, respectively). Baroreceptor discharge responses were obtained as MAP
was lowered to 50 mmHg and raised to 200 mmHg from baseline. MAP and
AoNA were allowed to recover between pressure ramps. Baroreceptor discharge curves were obtained before (control, C) 15 min after 3
-OH-DHP (E1, 220 µg/kg bolus + 22 µg · kg
1 · min
1 infusion
iv), and again 15 min after a second dose of 3
-OH-DHP (E2, 220 µg/kg bolus + 22 µg · kg
1 · min
1 infusion
iv). Previously, a similar treatment regimen was shown to attenuate
baroreflex-mediated sympathoexcitatory responses (15, 23).
The goal in these previous studies was to achieve low micromolar
concentrations of 3
-OH-DHP (~2 µM) that would be immediately
available to the CNS via the circulation, and would be within
the feasible range for endogenous CNS concentrations (23).
The same treatment regimen was used in the current experiments to
determine whether doses of 3
-OH-DHP known to affect baroreflex control of sympathetic nerve activity, had an effect on afferent baroreceptor nerve activity. Because arterial baroreceptors are sensitive to the rate of change of pressure, care was taken to ensure
that the rate of decreases and increases in MAP was consistent between
curves. The animals were then killed at the end of the experiment via
an overdose of anesthetic, and any nerve activity signal remaining
after 30 min was defined as electrical noise. The pups of pregnant
animals were counted and weighed to ensure that pup weight was normal
for the day of pregnancy.
Data Analysis
Because absolute multiunit nerve activity values are dependent on recording conditions, nerve activity was standardized as a percentage of the initial baseline of the control curve.Data obtained in the efferent nerve activity baroreflex experiments
were fitted to the following nonlinear logistic curve equation
(19)
|
|
|
|
|
|
Linear regressions on the linear portion of the RSNA or AoNA discharge response to NTP and also to PE were performed to separately evaluate the sensitivity to hypotensive and hypertensive challenges.
Unpaired t-tests were used for comparisons of parameters
between virgin and pregnant rats and one-way ANOVA with repeated measures, followed by Student-Newman-Keuls post hoc test was used to
evaluate the response to 3
-OH-DHP for a given parameter within each
group. Data are presented as means ± SE. P
0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Effects of Pregnancy on RSNA Baroreflex Curves
Prior studies in our laboratory have evaluated the effects of pregnancy on baroreflex function in chloralose-anesthetized (7) and in conscious (23) rats. Whereas evidence for attenuated sympathoexcitatory responses was observed in pregnant chloralose-anesthetized rats, the sympathoexcitatory responses were relatively small in the anesthetized compared with the conscious preparation. Preliminary experiments using the anesthetic Inactin were performed in 13 virgin and 14 pregnant animals to evaluate whether this may be due to the type of anesthetic used. The results indicated that under Inactin anesthesia, responses similar to those obtained in chloralose-anesthetized animals were observed and at high MAP were more similar to responses in conscious animals (Fig. 1). In pregnant rats, the RSNA baroreflex function curve midpoint (A3) tended to be lower (pregnant = 118 ± 2.4, virgin = 126 ± 2.8 mmHg, P < 0.056) suggesting a shift in the curve to a lower operating pressure range. Consistent with this trend, baseline MAP was significantly lower in pregnant (104 ± 3.1 mmHg) compared with virgin (121 ± 3.3 mmHg) animals. Slope of the NTP portion of the curve tended (P < 0.08) to be decreased in pregnant (
1.9 ± 0.27) compared with virgin (
2.6 ± 0.32) rats,
suggesting that during pregnancy, sympathoexcitatory responses to low
MAP may be attenuated. Meanwhile, a significantly lower minimum NA (A4) in pregnant rats (pregnant = 11 ± 2.8, virgin = 22 ± 3.2% baseline) indicated that sympathoinhibitory responses were
potentiated at high MAP. Thus although not as pronounced as in
conscious rats, potentiated sympathoinhibition and a tendency for
attenuated sympathoexcitation are evident in pregnant
Inactin-anesthetized rats.
|
The effect of pregnancy on baseline HR and HR range in these Inactin-anesthetized rats was also evaluated in these experiments. HR data were obtained in 13 pregnant and 9 virgin animals. Baseline HR was significantly higher in pregnant compared with virgin animals (pregnant = 408 ± 8.0 beats/min, virgin = 359 ± 7.5 beats/min). However, no difference was observed in baroreflex HR range between pregnant and virgin groups (pregnant = 46 ± 7.4 beats/min, virgin = 53 ± 10.1 beats/min).
Effects of Pregnancy on Aortic Nerve Discharge Curves
The effect of pregnancy on aortic depressor nerve activity was evaluated in 12 virgin and 12 pregnant rats and the results are summarized in Table 1. Baseline MAP was significantly lower in pregnant compared with virgin rats. A significant decrease in the baroreceptor discharge curve midpoint (A3) was also observed indicating a leftward shift of the curve during pregnancy (Fig. 2). There were, however, no significant differences in any of the other curve coefficients (NA range, slope coefficient, or maximum NA). Similarly, the calculated parameters, minimum NA, and maximum slope were not significantly different between virgin and pregnant animals. Further comparison of the slopes of the baroreceptor response to NTP and PE were performed using linear regression analysis of the linear portion of the NTP and PE ends of the curve, and neither NTP nor PE slopes were found to be different between the two groups.
|
|
The effect of pregnancy on baseline HR and baroreflex HR range was also evaluated. As expected, pregnancy was associated with a significantly higher baseline HR (pregnant = 431 ± 8.8 beats/min, virgin = 378 ± 7.1 beats/min). Baroreflex HR range, however, was not different between pregnant and virgin groups (pregnant = 59 ± 9.9 beats/min, virgin = 45 ± 7.4 beats/min). Because baroreflex-induced changes in HR were minimal in anesthetized rats, baroreflex HR responses were not evaluated further.
Effects of 3
-OH-DHP
-OH-DHP, on baroreceptor discharge was evaluated
in 12 virgin and 12 pregnant rats and the results are summarized in
Tables 2 and
3.
|
|
Intravenous administration of 3
-OH-DHP to virgin animals had no
effect on baseline MAP or baseline raw NA compared with control. No
significant effect on the baroreceptor discharge curve coefficients (A1-A4) was observed after administration of
3
-OH-DHP (Table 2, Fig. 3). Likewise,
the calculated parameters (minimum NA and maximum slope) were not
different from control. Analysis of the NTP and PE slopes showed that
there was no effect of 3
-OH-DHP on sensitivities at either end of
the curve (Table 2). Baseline HR and HR range were also unaffected by
the administration of 3
-OH-DHP (not shown).
|
The effect of exogenous 3
-OH-DHP administration in pregnant animals
was also evaluated. As in the virgin group, no effect of 3
-OH-DHP on
baseline MAP or baseline raw NA was observed. Baroreceptor discharge
curve coefficients (A1-A4) after the
administration of 3
-OH-DHP, were not different from control (Table
3, Fig. 4). Similarly, minimum NA,
maximum slope, and NTP and PE slopes were not different (Table 3).
Baseline HR and HR range were also unaffected by 3
-OH-DHP in
pregnant animals (not shown).
|
These results indicate that unlike the baroreflex efferent nerve
activity responses observed in previous studies in our laboratory (15, 23) 3
-OH-DHP has no effect on afferent discharge
curves in either virgin or pregnant animals.
| |
DISCUSSION |
|---|
|
|
|---|
There are a number of cardiovascular adaptations associated with pregnancy including increases in blood volume, cardiac output, and HR and a decrease in arterial pressure (10, 11, 17, 21). Similar to other reports, a decrease in baseline arterial pressure and tachycardia were observed in the pregnant rats in the current study. Among the adaptations to pregnancy are changes in arterial baroreflex function. Previous studies in our laboratory have demonstrated that the lower baseline blood pressure during pregnancy is associated with a decrease in the midpoint of the baroreflex function curve to a lower operating pressure range. In addition, sympathoexcitatory responses to decreases in arterial blood pressure are attenuated, and an increased sympathoinhibition occurs at high blood pressures in pregnant compared with virgin rats (7, 15, 23). The effects of pregnancy on baroreflex control of efferent renal sympathetic nerve activity were verified in Inactin-anesthetized rats in the current study.
The changes in baroreflex function observed during pregnancy may be
due, in part, to the presence of elevated levels of the primary
metabolite of progesterone 3
-OH-DHP the most potent positive modulator of CNS GABAA receptors. In pregnant women, serum
progesterone and 3
-OH-DHP levels increase significantly throughout
gestation, with no major changes at normal delivery (22).
In rats, plasma levels of progesterone and the major metabolites of
progesterone peak around the day designated as day 16 of
pregnancy in our study, and then fall rapidly during the last couple of
days of gestation. However, cerebrocortical concentrations of
3
-OH-DHP do not peak until the day we designate as day 20 of pregnancy (5). Thus it is likely that CNS 3
-OH-DHP
levels are elevated in the pregnant rats in this and previous studies
from our laboratory (7, 15, 23).
Previous studies evaluating the effect of 3
-OH-DHP on baroreflex
function have demonstrated that acute intravenous administration of
3
-OH-DHP to virgin female rats attenuates efferent baroreflex sympathoexcitatory responses (15, 23). This response
mimics an effect of pregnancy on baroreflex function and is consistent with a CNS mechanism of action but could also be due to effects on
afferent baroreceptor discharge. Thus the current experiments were
designed to evaluate the effects of pregnancy and 3
-OH-DHP on the
afferent limb of the baroreflex.
The effect of pregnancy on the afferent limb of the baroreflex was evaluated by recording aortic nerve activity responses to changes in pressure. A significant decrease in baseline MAP and a shift in the baroreceptor discharge curve midpoint to the left was observed in pregnant animals. However, the other curve parameters [baroreceptor discharge curve range (A1), slope coefficient (A2), maximum NA (A4), minimum NA] and responsiveness to hypotensive and hypertensive challenges (maximum slope, NTP slope, and PE slope) were not different. Others have demonstrated that exposure to chronic (18, 28) and acute (4, 3) hypotension results in a parallel shift of the baroreceptor discharge curve to lower operating pressures, with no change in sensitivity to increments in pressure. Thus the results from the current experiments are consistent with a pressure-dependent hypotensive resetting of the baroreceptors in pregnant rats. The baroreceptor function curve of pregnant rats exhibited a parallel shift in the direction of the prevailing pressure with no change in slope. Although responses to longer-term changes in arterial pressure differed, Hines (16) found that, similar to the current study, short-term changes in arterial pressure produced by bolus injections of PE and NTP, elicited equivalent changes in aortic depressor nerve activity in virgin and pregnant rats, suggesting no change in baroreceptor gain. The leftward shift of the baroreceptor afferent nerve discharge curve seen in the current experiments likely contributes to the leftward shift of the baroreflex curve that occurs in pregnancy (current Fig. 1, and Refs. 7, 23). However, pressure-dependent downward resetting of baroreceptors is characterized by a parallel leftward shift of the function curve along the pressure axis with no effect on sensitivity to increments in pressure (4, 14, 18). Thus mechanisms other than pressure-dependent baroreceptor resetting must account for the attenuated sympathoexcitatory and the potentiated sympathoinhibitory baroreflex responses seen in pregnant animals.
In contrast to the effects of 3
-OH-DHP to attenuate baroreflex
sympathoexcitatory responses (15, 23), acute
administration of 3
-OH-DHP to virgin rats did not have an effect on
the baroreceptor afferent nerve discharge curve. HR was also unaffected
by 3
-OH-DHP. Similarly, the administration of 3
-OH-DHP to
pregnant rats did not affect either the baroreceptor afferent nerve
discharge curve or HR range. The plasma concentrations of circulating
3
-OH-DHP achieved in the current experiments (~2 µM, Ref.
23), most likely exceed the maximum plasma concentrations
present during pregnancy (~0.13 µM, Ref. 5). Although
not specifically measured in brain regions involved in control of
cardiovascular function, it has been reported that compared with plasma
levels 3
-OH-DHP levels may be 10- to 100-fold higher in some brain
regions (27). Thus a higher dose of 3
-OH-DHP was used
in the previous experiments to achieve concentrations that would be
immediately available to the CNS via the circulation and would be
within a feasible range for physiological CNS concentrations. Because a
similar treatment regimen resulted in attenuated baroreflex
sympathoexcitation (15, 23) but had no effect on afferent
aortic baroreceptor function in the current experiments, it appears
that changes in afferent baroreceptor input do not contribute to the
attenuated baroreflex sympathoexcitatory responses due to intravenous
3
-OH-DHP administration. Therefore, the effect of intravenous
3
-OH-DHP on baroreflex function most likely occurs at the level of
the CNS.
The effect of 3
-OH-DHP to potentiate GABAergic inhibition within the
CNS is well known (25, 26). GABA receptors are ubiquitous within the CNS and tonic GABAergic inhibition has been demonstrated in
the major brainstem nuclei participating in the baroreflex pathway.
GABA likely modulates, but does not initiate, baroreflex-induced changes in sympathetic outflow at the level of the nucleus tractus solitarius and the caudal ventrolateral medulla. In contrast, changes
in GABA receptor activation within the RVLM are of primary importance
in mediating baroreflex-induced changes in sympathetic efferent nerve
activity in response to changes in arterial blood pressure
(9). Previous experiments from our laboratory demonstrated that intravenous administration of 3
-OH-DHP altered sympathetic nerve activity responses to changes in arterial pressure that would be
consistent with potentiated GABAergic inhibition in the RVLM, but not
the nucleu tractus solitariuus or caudal ventrolateral medulla
(15, 23). Thus additional experiments tested the
possibility that 3
-OH-DHP potentiated inhibition within the
RVLM. Extracellular recordings were made from presumed presympathetic,
spinally projecting, baroreflex-sensitive neurons in the rostral
ventrolateral medulla. Intravenous administration of 3
-OH-DHP
decreased the arterial pressure threshold for inhibition of these
neurons (20), which is consistent with the potentiated
baroreflex sympathoinhibition seen in pregnancy (7, 15,
23). In addition, a preliminary report demonstrated that local
microinjection of 3
-OH-DHP into the RVLM resulted in attenuated
baroreflex sympathoexcitatory responses (13).
| |
PERSPECTIVES |
|---|
|
|
|---|
Previous studies (7, 15, 23) in our laboratory have
demonstrated that pregnancy is associated with a decreased MAP, a shift
in the baroreflex function curve to a lower operating pressure range,
potentiated baroreflex sympathoinhibition, and attenuated baroreflex
sympathoexcitation. Acute intravenous administration of 3
-OH-DHP,
the primary metabolite of progesterone and the most potent endogenous
positive modulator of CNS GABAA receptor function (25, 26), attenuates efferent baroreflex
sympathoexcitatory responses similar to the effect of pregnancy. These
results are consistent with increased GABAergic influence in CNS sites
controlling sympathetic outflow in pregnant animals. Recent studies
evaluating the effect of 3
-OH-DHP on the rostral ventrolateral
medulla, have demonstrated changes in neuronal discharge
(20) and baroreflex function (13) consistent
with effects observed during pregnancy (7, 15, 23). The
current experiments were designed to evaluate the effects of pregnancy
and 3
-OH-DHP on the afferent limb of the baroreflex. In this study,
a significant parallel leftward shift of the baroreceptor discharge
curve to a lower operating pressure in pregnant animals was observed,
which is consistent with a pressure-dependent resetting. This downward
resetting of the baroreceptor function curve likely contributes to the
shift of the baroreflex curve to a lower operating pressure range in pregnant animals. The administration of 3
-OH-DHP, however, did not
have an effect on the afferent nerve discharge in either virgin or
pregnant animals. These results indicate that the previously observed
effects of 3
-OH-DHP on the baroreflex are most likely due to a
central mechanism of action and may contribute to the attenuated
sympathoexcitation seen in pregnant compared with virgin animals.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Sarbani Ghosh, Jessica Lee, Tomohiro Nakayama, and Hitomi Nakayama for expert technical assistance and advice in performing these experiments.
| |
FOOTNOTES |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grant R01-HL-36245 (to C. M. Heesch).
Address for reprint requests and other correspondence: C. M. Heesch, Univ. of Missouri, Dalton Cardiovascular Research Center, Research Park, Columbia, MO 65211-3300 (E-mail: heeschc{at}missouri.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 13 April 2000; accepted in final form 1 August 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Brooks, V,
Quesnell R,
Cumbee S,
and
Bishop V.
Pregnancy attenuates activity of the baroreceptor reflex.
Clin Exp Pharmacol Physiol
22:
152-156,
1995[ISI][Medline].
2.
Chapleau, MW.
Are arterial pressure and deformation the sole determinants of baroreceptor activity? Importance of humoral and endothelial modulation in normal and disease states.
Hypertension
19:
278-280,
1992
3.
Chapleau, MW,
and
Abboud FM.
Modulation of baroreceptor activity by ionic and paracrine mechanisms: an overview.
Braz J Med Biol Res
27:
1001-1015,
1994[ISI][Medline].
4.
Coleridge, H,
Coleridge J,
Kaufman M,
and
Dangel A.
Operational sensitivity and acute resetting of aortic baroreceptors in dogs.
Circ Res
48:
676-684,
1981
5.
Concas Follesa, AP,
Barbaccia ML,
Purdy RH,
and
Biggio G.
Physiological modulation of GABAA receptor plasticity by progesterone metabolites.
Eur J Pharmacol
375:
225-235,
1999[ISI][Medline].
6.
Costa, E.
From GABAA receptor diversity emerges a unified vision of GABAergic inhibition.
Annu Rev Pharmacol Toxicol
38:
321-350,
1998[ISI][Medline].
7.
Crandall, ME,
and
Heesch CM.
Baroreflex control of sympathetic outflow in pregnant rats: effects of captopril.
Am J Physiol Regulatory Integrative Comp Physiol
258:
R1417-R1423,
1990
8.
Curtis, KS,
Cunningham JT,
and
Heesch CM.
Fos expression in brain stem nuclei of pregnant rats after hydralazine-induced hypotension.
Am J Physiol Regulatory Integrative Comp Physiol
277:
R532-R540,
1999
9.
Dampney, RAL
Functional organization of central pathways regulating the cardiovascular system.
Physiol Rev
74:
323-364,
1994
10.
DeSwiet, M.
The cardiovascular system.
In: Clinical Physiology in Obstetrics, edited by Chamberlin G,
and Broughton-Pipkin F.. Oxford, UK: Blackwell, 1991, p. 3-38.
11.
DeSwiet, M.
The physiology of normal pregnancy.
In: Hypertension in Pregnancy, edited by Rubin P.. New York: Elsevier, 1988, p. 1-9.
12.
Garrett, KM,
Barron KW,
Briscoe R,
and
Heesch CM.
Neurosteroid modulation of [3H]flunitrazepam binding in the medulla: an autoradiographic study.
Brain Res
768:
301-309,
1997[ISI][Medline].
13.
Heesch, C,
Laiprasert J,
Rogers R,
and
Ghosh S.
Effects of 3-alpha-OH-dihydroprogesterone (3-alpha-OH-DHP) in the rostral ventrolateral medulla (RVLM) of female rats (Abstract).
Soc Neurosci Abstr
23:
53,
1997.
14.
Heesch, C,
Thames M,
and
Abboud F.
Acute resetting of carotid sinus baroreceptors I. Dissociation between discharge and wall changes.
Am J Physiol Heart Circ Physiol
247:
H824-H832,
1984
15.
Heesch, CM,
and
Rogers RC.
Effects of pregnancy and progesterone metabolites on regulation of sympathetic outflow.
Clin Exp Pharmacol Physiol
22:
136-142,
1995[ISI][Medline].
16.
Hines, T.
Baroreceptor afferent discharge in the pregnant rat.
Am J Physiol Regulatory Integrative Comp Physiol
278:
R1433-R1440,
2000
17.
Humphreys, P,
and
Joels N.
Changes in cardiac output and total peripheral resistance during the carotid sinus baroreceptor reflex in pregnant rabbit.
J Physiol (Lond)
239:
89-102,
1977.
18.
Igler, F,
Donegan J,
Hoo K,
Korns M,
and
Kampine J.
Chronic localized hypotension and resetting of carotid sinus baroreceptors: Electrophysiological and histological studies in the dog.
Circ Res
49:
649-654,
1981
19.
Kent, BB,
Drane JW,
Blumenstein B,
and
Manning JW.
A mathematical model to assess changes in the baroreceptor reflex.
Cardiology
57:
295-310,
1972[ISI][Medline].
20.
Laiprasert, J,
Rogers R,
and
Heesch C.
Neurosteroid modulation of arterial baroreflex-sensitive neurons in rat rostral ventrolateral medulla.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R903-R911,
1998
21.
Lindheimer, M,
and
Katz A.
Renal physiology and disease in pregnancy.
In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW,
and Giebisch G.. New York: Raven, 1992, p. 3371-3432.
22.
Luisi Petraglia, SF,
Benedetto C,
Nappi RE,
Bernardi F,
Fadalti M,
Reis FM,
Luisi M,
and
Genazzani AR.
Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients.
J Clin Endocrinol Metab
85:
2429-2433,
2000
23.
Masilamani, S,
and
Heesch CM.
Effects of pregnancy and progesterone metabolites on arterial baroreflex in conscious rats.
Am J Physiol Regulatory Integrative Comp Physiol
272:
R924-R934,
1997
24.
Numao, Y,
Siato M,
Terui N,
and
Kumada M.
The aortic nerve-sympathetic reflex in the rat.
J Auton Nerv Syst
13:
65-79,
1985[ISI][Medline].
25.
Orchinik, M,
and
McEwen B.
Novel and classical actions of neuroactive steroids.
Neurotransmissions
9:
1-6,
1993.
26.
Paul, SM,
and
Purdy RH.
Neuroactive steroids.
FASEB J
6:
2311-2322,
1992[Abstract].
27.
Purdy, RH,
Morrow AL,
Moore PH, Jr,
and
Paul SM.
Stress-induced elevations of
-aminobutyric acid type A receptor-active steroids in the rat brain.
Neurobiology (Bp)
88:
4553-4557,
1991.
28.
Salgado, HC,
and
Krieger EM.
Time course of baroreceptor resetting in short-term hypotension in the rat.
Am J Physiol Heart Circ Physiol
234:
H552-H556,
1978.
29.
Sapru, HN,
Gonzalez E,
and
Krieger AJ.
Aortic nerve stimulation in the rat: cardiovascular and respiratory responses.
Brain Res Bull
6:
393-398,
1981[ISI][Medline].
This article has been cited by other articles:
![]() |
M. A. Herman, M. Niedringhaus, A. Alayan, J. G. Verbalis, N. Sahibzada, and R. A. Gillis Characterization of noradrenergic transmission at the dorsal motor nucleus of the vagus involved in reflex control of fundus tone Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R720 - R729. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kvochina, E. M. Hasser, and C. M. Heesch Pregnancy increases baroreflex-independent GABAergic inhibition of the RVLM in rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2295 - R2305. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Daubert, M.-Y. Chung, and V. L. Brooks Insulin resistance and impaired baroreflex gain during pregnancy Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2188 - R2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Storey and S. Kaufman Effect of pregnancy and 5{alpha}-pregnan-3{alpha}-ol-20-one on atrial receptor afferent discharge in rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1427 - R1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Brooks, K. A. Clow, and K. P. O'Hagan Pregnancy and acute baroreflex resetting in conscious rabbits Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R429 - R440. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |